Therapeutic Segment
 Anti-lipidemic

 Generic Name
 Fenofibrate

 Indication 
 It is indicated as adjunctive therapy to diet for the reduction of LDL-C, Total-C, Triglycerides and Apo B in adult patients with primary hypercholesterolemia or mixed dyslipidemia (Fredrickson Type IIa and IIb). Fenoget is indicated as adjunctive therapy to diet for the treatment of adult patients with hypertriglyceridemia (Fredrickson types IV and V hyperlipidemia).

 Brand
 Fenoget

 Form
 Capsules